Effects of hexanic extract of serenoa repens (permixon(®) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia

BACKGROUND: Chronic prostatic inflammation (CPI) could be a cause of symptomatic or complicated benign prostatic hyperplasia (BPH). In previous in vitro and in vivo studies, Hexanic Extract of Serenoa repens (HESr) namely Permixon(®) has demonstrated potent anti‐inflammatory properties. With the aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Latil, Alain, Pétrissans, Marie‐Thérèse, Rouquet, Jérôme, Robert, Grégoire, de la Taille, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049653/
https://www.ncbi.nlm.nih.gov/pubmed/26306400
http://dx.doi.org/10.1002/pros.23059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049653/
https://www.ncbi.nlm.nih.gov/pubmed/26306400
http://dx.doi.org/10.1002/pros.23059

Ejemplares similares